Oropharyngeal Dysplasia

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Aveta Biomics
Aveta BiomicsMA - Bedford
1 program
1
APG-157Phase 21 trial
Active Trials
NCT05865028RecruitingEst. May 2028

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
Aveta BiomicsAPG-157

Clinical Trials (1)

A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

Start: May 2023Est. completion: May 2028
Phase 2Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space